Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Progressive Breast Cancer”

101 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 101 results

Testing effectiveness (Phase 2)Study completedNCT06375707
What this trial is testing

First-Line Ribociclib Plus Endocrine Therapy Versus Chemotherapy With or Without Subsequent Endocrine Therapy in Patients With Rapidly Progressive HR-Positive/HER2-Negative Advanced Breast Cancer

Who this might be right for
Advanced Breast Cancer
The First Affiliated Hospital with Nanjing Medical University 74
Not applicableStudy completedNCT01275872
What this trial is testing

Effect of Guided Imagery and Progressive Muscle Relaxation as a Means to Improve the Psychological Well-being and the Quality of Life for Patients With Breast and Prostate Cancer

Who this might be right for
Breast CancerProstate Cancer
Cyprus University of Technology 200
Large-scale testing (Phase 3)Study completedNCT00103233
What this trial is testing

Vinorelbine With or Without Trastuzumab in Treating Women With Progressive Metastatic Breast Cancer

Who this might be right for
Breast Cancer
SWOG Cancer Research Network
Not applicableStudy completedNCT06098118
What this trial is testing

Adapting a Mammography Decision Aid to Support Women Living in a Community Contaminated by PFAS

Who this might be right for
Breast Cancer Screening
Trustees of Dartmouth College 100
Testing effectiveness (Phase 2)Looking for participantsNCT05866432
What this trial is testing

Phase II Study of Dato-DXd in Triple-negative Breast Cancer Patients With Newly Diagnosed or Progressing Brain Metastases

Who this might be right for
Breast Cancer Stage IV
Medical University of Vienna 20
Not applicableStudy completedNCT01106820
What this trial is testing

Progressive Resistance Training Versus Relaxation for Breast Cancer Patients During Chemotherapy: Biological Mechanisms and Effects on Fatigue and Quality of Life

Who this might be right for
Breast CancerCancer-related Fatigue
German Cancer Research Center 101
Large-scale testing (Phase 3)Study completedNCT00081796
What this trial is testing

Breast Cancer Trial of RPR109881 Versus Capecitabine in Male or Female Patients With Advanced Breast Cancer

Who this might be right for
Breast CancerMetastases
Sanofi 438
Not applicableStudy completedNCT00916162
What this trial is testing

Drug Withdrawal in Women With Progressive Breast Cancer While on Aromatase Inhibitor Therapy

Who this might be right for
Breast Cancer
Massachusetts General Hospital 24
Early research (Phase 1)Ended earlyNCT02414776
What this trial is testing

Hydroxychloroquine in Metastatic Estrogen Receptor-Positive Breast Cancer Progressing on Hormonal Therapy

Who this might be right for
Estrogen Receptor Positive Breast Cancer
Western Regional Medical Center 3
Testing effectiveness (Phase 2)UnknownNCT02175446
What this trial is testing

Safety and Efficacy Study of Eribulin in Combination With Bevacizumab for Second-line Treatment HER2- MBC Patients

Who this might be right for
Metastatic Breast CancerHuman Epidermal Growth Factor 2 Negative Carcinoma of Breast
Consorzio Oncotech 61
Not applicableLooking for participantsNCT06103669
What this trial is testing

Locally ablatiVe therApy in oLigO-pRogressive sOlid tUmorS (VALOROUS)

Who this might be right for
Breast CancerOligoprogressiveHead and Neck Cancer+2 more
University of California, Davis 250
Large-scale testing (Phase 3)UnknownNCT00688194
What this trial is testing

Fulvestrant With or Without Lapatinib and/or Aromatase Inhibitor Therapy in Treating Postmenopausal Women With Metastatic Breast Cancer That Progressed After Previous Aromatase Inhibitor Therapy

Who this might be right for
Breast Cancer
Gruppo Italiano Mammella (GIM) 396
Testing effectiveness (Phase 2)WithdrawnNCT01479179
What this trial is testing

Trastuzumab in Combination With AMG 479 in HER-2 Overexpressing MBC Progressing on Trastuzumab

Who this might be right for
Breast Cancer
M.D. Anderson Cancer Center
Not applicableStudy completedNCT05022823
What this trial is testing

Exercise and Compression for Lymphedema

Who this might be right for
Breast Cancer Related Lymphedema
AHS Cancer Control Alberta 40
Testing effectiveness (Phase 2)Ended earlyNCT01477060
What this trial is testing

Modulation of Response to Hormonal Therapy With Lapatinib and/or Metformin in Patients With Metastatic Breast Cancer

Who this might be right for
Metastatic Breast Cancer
Fondazione Michelangelo 32
Testing effectiveness (Phase 2)Study completedNCT01441596
What this trial is testing

Lux-Breast 3; Afatinib Alone or in Combination With Vinorelbine in Patients With Human Epidermal Growth Factor Receptor 2 (HER2) Positive Breast Cancer Suffering From Brain Metastases

Who this might be right for
Breast NeoplasmsNeoplasm Metastasis
Boehringer Ingelheim 121
Testing effectiveness (Phase 2)Active Not RecruitingNCT03808662
What this trial is testing

Randomized Study of Stereotactic Body Radiation Therapy (SBRT) in Patients With Oligoprogressive Metastatic Cancers of the Breast and Lung

Who this might be right for
TNBC - Triple-Negative Breast CancerTriple Negative Breast CancerNSCLC+4 more
Memorial Sloan Kettering Cancer Center 107
Large-scale testing (Phase 3)UnknownNCT02394496
What this trial is testing

Overcoming Endocrine Resistance in Metastatic Breast Cancer

Who this might be right for
Metastatic Breast Cancer
Consorzio Oncotech 396
Testing effectiveness (Phase 2)Study completedNCT01677455
What this trial is testing

An Open-Label Multicenter Phase 2 Window of Opportunity Study Evaluating Ganetespib in Women With Breast Cancer

Who this might be right for
Breast CancerHER-2 Positive Breast CancerTriple Negative Breast Cancer+1 more
Synta Pharmaceuticals Corp. 51
Testing effectiveness (Phase 2)Study completedNCT00327743
What this trial is testing

Combination Study of a New Taxane and Capecitabine in Patients With Metastatic Breast Cancer

Who this might be right for
Breast CancerCancer
Sanofi 34
Next Page